Central serous retinopathy — also called central serous chorioretinopathy, or CSR — occurs when fluid collects beneath the retina at the macula, lifting it away from the layer underneath and blurring central vision.

It stands apart from most retinal conditions in who it affects. Patients are frequently in their thirties, forties or fifties rather than their seventies, and are often otherwise healthy, which makes the diagnosis unexpected.

What patients describe

Symptoms usually affect one eye and develop over days.

  • A blurred, dim or gray spot in the center of vision
  • Straight lines appearing bent or wavy
  • Objects appearing smaller in the affected eye than in the other
  • Colors seeming muted or slightly brown-tinted
  • Reduced contrast, with a sense that vision is dull rather than sharply blurred
  • Difficulty focusing on near work, sometimes with a mild shift toward farsightedness

Vision loss is generally mild to moderate rather than severe, and the peripheral field is unaffected. Many patients describe it as looking through a smudge or a bubble.

Why the fluid accumulates

Beneath the retina is a layer of cells that normally pumps fluid out of the subretinal space, keeping the retina flat and attached. In central serous retinopathy the vascular layer beneath becomes thickened and leaky, and that pumping mechanism is overwhelmed. Fluid collects, and the retina above it detaches into a shallow blister.

The condition is strongly associated with corticosteroid exposure in any form — oral, inhaled, nasal, topical on the skin, or by injection. It is also associated with psychological stress, with certain personality patterns, and it occurs more frequently in men than women, and in people with obstructive sleep apnea.

Identifying an avoidable contributor is a genuinely useful part of the evaluation, because removing it often changes the course of the condition.

Diagnosis

Optical coherence tomography is the primary test and usually makes the diagnosis immediately, showing a clearly defined pocket of fluid beneath the macula. It also quantifies the fluid, allowing resolution to be tracked precisely at follow-up visits.

Fluorescein angiography can identify the point of leakage, which matters if treatment directed at that point is being considered. Indocyanine green angiography shows the abnormal vessels in the layer beneath and is used in more complex or recurrent cases. OCT angiography may be used to exclude abnormal new vessel growth, which can complicate long-standing disease.

A careful medication history is part of the evaluation. Patients are often unaware that a steroid nasal spray, skin cream or joint injection counts, and these are easy to overlook unless asked about directly.

Management

Many acute episodes resolve without intervention over a period of a few months as the fluid reabsorbs, and observation is a legitimate first approach in a first episode. That does not mean nothing is done.

  • Stopping corticosteroid exposure wherever medically possible is the single most useful step, and should be coordinated with the physician who prescribed it rather than done unilaterally.
  • Addressing sleep apnea where it is present or suspected.
  • Reducing modifiable stress, which is more easily said than achieved but is genuinely associated with the condition’s course.

Where fluid persists beyond several months, recurs, or affects an eye that has already sustained damage, treatment may be considered. Photodynamic therapy directed at the leaking area and certain laser approaches are the established options; the choice depends on where the leakage is and how long it has been present. Anti-VEGF injections have a role only where abnormal new vessels have developed as a complication.

The reason persistent fluid is not left indefinitely is that prolonged separation of the retina can cause lasting change to the cells above it, and outcomes relate to duration.

Recurrence and longer-term outlook

Central serous retinopathy recurs in a substantial minority of patients, sometimes in the same eye and sometimes the other. Recurrence does not necessarily mean the condition is worsening, but repeated or prolonged episodes are what lead to lasting change, so they are followed more actively.

Patients are usually advised to monitor their own central vision, one eye at a time, using an Amsler grid or a simple fixed target at home, and to report a new blur, distortion or dim spot rather than waiting for a scheduled appointment.

Knowing that corticosteroids are a trigger is worth carrying forward: mention the diagnosis to any physician considering a steroid for another condition, so the decision can be made with that in mind.

Central serous retinopathy: common questions

It involves a shallow separation of the retina from the layer beneath, caused by fluid rather than by a tear, and it is a distinct condition from the retinal detachment that follows a retinal break. It does not carry the same urgency and is not treated surgically in the way a rhegmatogenous detachment is.

Vision commonly improves as the fluid resolves, and many patients recover well after a first episode. Recovery tends to be less complete when fluid has been present for a long period or after repeated episodes, which is the reason persistent fluid is treated rather than observed indefinitely.

Yes. Corticosteroids in any form — including nasal sprays, inhalers, skin creams, eye drops and joint injections — are associated with central serous retinopathy, and patients frequently do not think of them as steroids. Tell your physician about all of them, and do not stop a prescribed medication without discussing it with the prescriber.

Stress is consistently associated with the condition, though the mechanism is not fully established and stress is not the whole explanation. It is reasonable to treat stress reduction as worthwhile alongside the rest of the evaluation, rather than as the sole intervention.

A first episode is often observed for a period of a few months, since many resolve on their own. Fluid persisting beyond that, recurrence, or involvement of an eye with previous damage all shift the balance toward treatment. Your physician will base the timing on your OCT findings.

Both eyes can be involved, either at the same time or in separate episodes, and changes are sometimes found in the second eye on imaging even when it has no symptoms. Both eyes are examined at each visit for that reason.

A dim or distorted spot in your central vision?

Central serous retinopathy is diagnosed quickly with OCT imaging. Call (602) 613-5473 to arrange an evaluation at our Scottsdale office, or contact us.